NORTHAMPTON, MA / ACCESS Newswire / June 16, 2025 / In remote communities in Argentina, access to quality healthcare is a ...

We're trying to set the stage for integrating these ideas" Anthony Vella, professor and Boehringer Ingelheim Chair in ...

The Lung Cancer Research Foundation (LCRF) announces today a new research collaboration with Boehringer Ingelheim creating two funding mechanisms designed to address HER2 mutations in lung cancer: a ...

Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, signed a Memorandum of Understanding (MoU) with ...

The Department of Health - Abu Dhabi (DoH) signed a Memorandum of Understanding with Boehringer Ingelheim, one of the world's ...

A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to ...

Echosens and Boehringer Ingelheim have expanded their collaboration aimed at expediting progress in metabolic ...

This expansion will change the trajectory of MASH by focusing on early detection, diagnosis, and access to care.

In a pharmaphorum podcast recorded onsite at the Congress, web editor Nicole Raleigh spoke with Itziar Canamasas, global head ...

By combining their diagnostic and therapeutic expertise, Echosens and Boehringer Ingelheim aim to help close persistent gaps ...

Originally designed as glucose-lowering medications, SGLT2 inhibitors provide benefits across the cardio-renal-metabolic ...

Biopharmaceutical company Boehringer Ingelheim is using data and more to drive organizational change and has outlined four ...